Rapid and simultaneous quantification of levetiracetam and its carboxylic metabolite in human plasma by liquid chromatography tandem mass spectrometry

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Yeap, Li Ling ^a   Lo, Yoke Lin ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONITRILE; DIPHENHYDRAMINE; DRUG METABOLITE; ETIRACETAM; PIRACETAM;

ADULT; ARTICLE; CENTRIFUGATION; CONTROLLED STUDY; DILUTION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG STORAGE; DRUG STRUCTURE; EPILEPSY; HUMAN; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; PRECIPITATION; QUANTITATIVE ASSAY; TANDEM MASS SPECTROMETRY; ANALOGS AND DERIVATIVES; BLOOD; METABOLISM; REPRODUCIBILITY; VALIDATION STUDY;

CHROMATOGRAPHY, LIQUID; EPILEPSY; HUMANS; LIMIT OF DETECTION; PIRACETAM; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY;

EID: 84910654981     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111544     Document Type: Article

References (45)

1. (2011) Keppra: Prescribing Information [Product Insert]. Smyrna, GA: UCB.
2. Patsalos PN (2000) Pharmacokinetic profile of levetiracetam: toward ideal characteristics. Pharmacol Ther 85:77-85.
3. Patsalos PN (2003) The pharmacokinetic characteristics of levetiracetam. Methods Find Exp Clin Pharmacol 25:123-129.
4. Patsalos PN (2004) Clinical pharmacokinetics of levetiracetam. Clin Pharmacokinet 43:707-724.
5. Patsalos PN, Ghattaura S, Ratnaraj N, Sander JW (2006) In situ metabolism of levetiracetam in blood of patients with epilepsy. Epilepsia 47:1818-1821.
6. May TW, Rambeck B, Jurgens U (2003) Serum concentrations of Levetiracetam in epileptic patients: the influence of dose and co-medication. Ther Drug Monit 25:690-699.
7. Patsalos PN (2013) Drug interactions with the newer antiepileptic drugs (AEDs) - part 1: pharmacokinetic and pharmacodynamic interactions between AEDs. Clin Pharmacokinet 52:927-966.
8. Patsalos PN (2013) Drug interactions with the newer antiepileptic drugs (AEDs) - Part 2: pharmacokinetic and pharmacodynamic interactions between AEDs and drugs used to treat non-epilepsy disorders. Clin Pharmacokinet 52:1045-1061.
9. Lancelin F, Franchon E, Kraoul L, Garciau I, Brovedani S, et al. (2007) Therapeutic drug monitoring of levetiracetam by high-performance liquid chromatography with photodiode array ultraviolet detection: preliminary observations on correlation between plasma concentration and clinical response in patients with refractory epilepsy. Ther Drug Monit 29:576-583.
10. Kaufman KR, Bisen V, Zimmerman A, Tobia A, Mani R, et al. (2013) Apparent dose-dependent levetiracetam-induced de novo major depression with suicidal behavior. Epilepsy and Behavior Case Reports 1:110-112.
11. Patsalos PN, Berry DJ, Bourgeois BF, Cloyd JC, Glauser TA, et al. (2008) Antiepileptic drugs-best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia. 2008/04/10 ed. pp. 1239-1276.
12. Reineks EZ, Lawson SE, Lembright KE, Wang S (2011) Performance characteristics of a new levetiracetam immunoassay and method comparison with a high-performance liquid chromatography method. Ther Drug Monit 33:124-127.
13. Shah NM, Hawwa AF, Millership JS, Collier PS, McElnay JC (2013) A simple bioanalytical method for the quantification of antiepileptic drugs in dried blood spots. J Chromatogr B Analyt Technol Biomed Life Sci 923-924:65-73.
14. Olah E, Bacsoi G, Fekete J, Sharma VK (2012) Determination of ng/mL levetiracetam using ultra-high-performance liquid chromatography-photodiode absorbance. J Chromatogr Sci 50:253-258.
15. Antonilli L, Brusadin V, Filipponi F, Guglielmi R, Nencini P (2011) Development and validation of an analytical method based on high performance thin layer chromatography for the simultaneous determination of lamotrigine, zonisamide and levetiracetam in human plasma. J Pharm Biomed Anal 56:763-770.
16. Zufia L, Aldaz A, Ibanez N, Giraldez J, Viteri C (2010) LC method for therapeutic drug monitoring of levetiracetam: evaluation of the assay performance and validation of its application in the routine area. Clin Biochem 43:473-482.
17. Contin M, Mohamed S, Albani F, Riva R, Baruzzi A (2008) Simple and validated HPLC-UV analysis of levetiracetam in deproteinized plasma of patients with epilepsy. J Chromatogr B Analyt Technol Biomed Life Sci 873:129-132.
18. Juenke J, Brown PI, Urry FM, McMillin GA (2006) Drug monitoring and toxicology: a procedure for the monitoring of levetiracetam and zonisamide by HPLC-UV. J Anal Toxicol 30:27-30.
19. Martens-Lobenhoffer J, Bode-Boger SM (2005) Determination of levetiracetam in human plasma with minimal sample pretreatment. J Chromatogr B Analyt Technol Biomed Life Sci 819:197-200.
20. Pucci V, Bugamelli F, Mandrioli R, Ferranti A, Kenndler E, et al. (2004) Highperformance liquid chromatographic determination of Levetiracetam in human plasma: comparison of different sample clean-up procedures. Biomed Chromatogr 18:37-44.
21. Grim SA, Ryan M, Miles MV, Tang PH, Strawsburg RH, et al. (2003) Correlation of levetiracetam concentrations between serum and saliva. Ther Drug Monit 25:61-66.
22. Ratnaraj N, Doheny HC, Patsalos PN (1996) A micromethod for the determination of the new antiepileptic drug levetiracetam (ucb LO59) in serum or plasma by high performance liquid chromatography. Ther Drug Monit 18:154-157.
23. Vermeij TA, Edelbroek PM (1994) High-performance liquid chromatographic and megabore gas-liquid chromatographic determination of levetiracetam (ucb L059) in human serum after solid-phase extraction. J Chromatogr B Biomed Appl 662:134-139.
24. Can NO, Arli G (2010) Reversed-phase HPLC analysis of levetiracetam in tablets using monolithic and conventional C18 silica columns. J AOAC Int 93:1077-1085.
25. Mecarelli O, Li Voti P, Pro S, Romolo FS, Rotolo M, et al. (2007) Saliva and serum levetiracetam concentrations in patients with epilepsy. Ther Drug Monit 29:313-318.
26. Isoherranen N, Roeder M, Soback S, Yagen B, Schurig V, et al. (2000) Enantioselective analysis of levetiracetam and its enantiomer R-alpha-ethyl-2-oxo-pyrrolidine acetamide using gas chromatography and ion trap mass spectrometric detection. J Chromatogr B Biomed Sci Appl 745:325-332.
27. Brockmoller J, Thomsen T, Wittstock M, Coupez R, Lochs H, et al. (2005) Pharmacokinetics of levetiracetam in patients with moderate to severe liver cirrhosis (Child-Pugh classes A, B, and C): characterization by dynamic liver function tests. Clin Pharmacol Ther 77:529-541.
28. Coupez R, Nicolas JM, Browne TR (2003) Levetiracetam, a new antiepileptic agent: lack of in vitro and in vivo pharmacokinetic interaction with valproic acid. Epilepsia 44:171-178.
29. Ivanova M, Piunti A, Marziali E, Komarova N, Raggi MA, et al. (2003) Microemulsion electrokinetic chromatography applied for separation of levetiracetam from other antiepileptic drugs in polypharmacy. Electrophoresis 24:992-998.
30. Luo W, Kong ST, Yang S, Chan BC, Ho PC (2013) A simple assay for determination of levetiracetam in rat dried blood spots by LC-MS/MS. Bioanalysis 5:1843-1851.
31. Collins JA, Janis GC (2012) Analysis of selected anticonvulsants by high performance liquid chromatography-tandem mass spectrometry. Methods Mol Biol 902:201-209.
32. Mendu DR, Soldin SJ (2010) Simultaneous determination of levetiracetam and its acid metabolite (ucb L057) in serum/plasma by liquid chromatography tandem mass spectrometry. Clin Biochem 43:485-489.
33. Matar KM (2008) Quantification of levetiracetam in human plasma by liquid chromatography-tandem mass spectrometry: application to therapeutic drug monitoring. J Pharm Biomed Anal 48:822-828.
34. Kim KB, Seo KA, Kim SE, Bae SK, Kim DH, et al. (2011) Simple and accurate quantitative analysis of ten antiepileptic drugs in human plasma by liquid chromatography/tandem mass spectrometry. J Pharm Biomed Anal 56:771-777.
35. Guo T, Oswald LM, Mendu DR, Soldin SJ (2007) Determination of levetiracetam in human plasma/serum/saliva by liquid chromatographyelectrospray tandem mass spectrometry. Clin Chim Acta 375:115-118.
36. Jain DS, Subbaiah G, Sanyal M, Pal U, Shrivastav PS (2006) Determination of levetiracetam in human plasma by liquid chromatography/electrospray tandem mass spectrometry and its application to bioequivalence studies. Rapid Commun Mass Spectrom 20:2539-2547.
37. Kuhn J, Knabbe C (2013) Fully validated method for rapid and simultaneous measurement of six antiepileptic drugs in serum and plasma using ultraperformance liquid chromatography-electrospray ionization tandem mass spectrometry. Talanta 110:71-80.
38. Shibata M, Hashi S, Nakanishi H, Masuda S, Katsura T, et al. (2012) Detection of 22 antiepileptic drugs by ultra-performance liquid chromatography coupled with tandem mass spectrometry applicable to routine therapeutic drug monitoring. Biomed Chromatogr 26:1519-1528.
39. Juenke JM, Brown PI, Johnson-Davis KL, McMillin GA (2011) Simultaneous quantification of levetiracetam and gabapentin in plasma by ultra-pressure liquid chromatography coupled with tandem mass spectrometry detection. Ther Drug Monit 33:209-213.
40. Blonk MI, van der Nagel BC, Smit LS, Mathot RA (2010) Quantification of levetiracetam in plasma of neonates by ultra performance liquid chromatographytandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 878:675-681.
41. Pellock JM, Glauser TA, Bebin EM, Fountain NB, Ritter FJ, et al. (2001) Pharmacokinetic study of levetiracetam in children. Epilepsia 42:1574-1579.
42. Food and Drug Administration Center for Drug Evaluation and Research (CDER) (2001) Guidance for industry: bioanalytical method validation. US Department of Health and Human Services. FDA Maryland.
43. European Medicines Agency (2011) Guideline on bioanalytical method validation. EMA London.
44. Glauser TA, Mitchell WG, Weinstock A, Bebin M, Chen D, et al. (2007) Pharmacokinetics of levetiracetam in infants and young children with epilepsy. Epilepsia 48:1117-1122.
45. Fountain NB, Conry JA, Rodriguez-Leyva I, Gutierrez-Moctezuma J, Salas E, et al. (2007) Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate. Epilepsy Res 74:60-69.